BRIEF-Molecular Partners presents preliminary results from the ongoing phase 2 study of MP0250
April 23 (Reuters) – Molecular Partners AG: * Said on Saturday had presented preliminary results from the ongoing phase 2 study of MP0250 at the European Myeloma Network Meeting in Turin Source text for Eikon: Further company coverage: (Gdynia Newsroom) Source Article